Di G - Search Results

1

An Optimization Study on Listening Experiments to Improve the Comparability of Annoyance Ratings of Noise Samples from Different Experimental Sample Sets.

Di G, Lu K, Shi X. Di G, et al. Int J Environ Res Public Health. 2018 Mar 8;15(3):474. doi: 10.3390/ijerph15030474. Int J Environ Res Public Health. 2018. PMID: 29518036 Free PMC article.

2

Influencing Factors Identification and Prediction of Noise Annoyance-A Case Study on Substation Noise.

Di G, Wang Y, Yao Y, Ma J, Wu J. Di G, et al. Int J Environ Res Public Health. 2022 Jul 9;19(14):8394. doi: 10.3390/ijerph19148394. Int J Environ Res Public Health. 2022. PMID: 35886248 Free PMC article.

3

Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.

Liu L, Zhang M, Cui N, Liu W, Di G, Wang Y, Xi X, Li H, Shen Z, Gu M, Wang Z, Jiang S, Liu B. Liu L, et al. Among authors: di g. PLoS One. 2024 Apr 18;19(4):e0298004. doi: 10.1371/journal.pone.0298004. eCollection 2024. PLoS One. 2024. PMID: 38635528 Free PMC article.

4

A case of solitary fibrous tumor of the left cerebellopontine angle region.

Li HB, Duan KQ, Di GF, Jiang XC. Li HB, et al. Among authors: di gf. Asian J Surg. 2024 Apr 12:S1015-9584(24)00631-6. doi: 10.1016/j.asjsur.2024.03.204. Online ahead of print. Asian J Surg. 2024. PMID: 38614851 Free article. No abstract available.

5

Ferroptosis in organ ischemia-reperfusion injuries: recent advancements and strategies.

Luan X, Chen P, Miao L, Yuan X, Yu C, Di G. Luan X, et al. Among authors: di g. Mol Cell Biochem. 2024 Mar 31. doi: 10.1007/s11010-024-04978-2. Online ahead of print. Mol Cell Biochem. 2024. PMID: 38556592 Review.

6

NLRP3 deficiency protects against acetaminophen‑induced liver injury by inhibiting hepatocyte pyroptosis.

Yuan X, Chen P, Luan X, Yu C, Miao L, Zuo Y, Liu A, Sun T, Di G. Yuan X, et al. Among authors: di g. Mol Med Rep. 2024 Apr;29(4):61. doi: 10.3892/mmr.2024.13185. Epub 2024 Feb 23. Mol Med Rep. 2024. PMID: 38391117 Free PMC article.

7

Corrigendum to "A Microanalytical Study of the far Lateral Approach" [World Neurosurgery 2019 Jul 127, 12033, e932-e942].

Di G, Fang X, Hu Q, Zhou W, Jiang X. Di G, et al. World Neurosurg. 2024 Apr;184:182-184. doi: 10.1016/j.wneu.2024.01.018. Epub 2024 Jan 25. World Neurosurg. 2024. PMID: 38387386 No abstract available.

8

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial.

Zuo WJ, Chen L, Shen Y, Wang ZH, Liu GY, Yu KD, Di GH, Wu J, Li JJ, Shao ZM. Zuo WJ, et al. Among authors: di gh. Ther Adv Med Oncol. 2024 Feb 14;16:17588359231225032. doi: 10.1177/17588359231225032. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38362377 Free PMC article.

9

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.

Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: di gh. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.

10

Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer.

Ding JH, Xiao Y, Yang F, Song XQ, Xu Y, Ding XH, Ding R, Shao ZM, Di GH, Jiang YZ. Ding JH, et al. Among authors: di gh. Sci Transl Med. 2024 Jan 3;16(728):eadg7740. doi: 10.1126/scitranslmed.adg7740. Epub 2024 Jan 3. Sci Transl Med. 2024. PMID: 38170790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page